91 related articles for article (PubMed ID: 33898322)
1. GZ17-6.02 Interacts With [MEK1/2 and B-RAF Inhibitors] to Kill Melanoma Cells.
Booth L; West C; Von Hoff D; Kirkwood JM; Dent P
Front Oncol; 2021; 11():656453. PubMed ID: 33898322
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of GZ17-6.02 resistance.
Booth L; West C; Von Hoff D; Dent P
Anticancer Drugs; 2022 Jun; 33(5):415-423. PubMed ID: 35276694
[TBL] [Abstract][Full Text] [Related]
3. A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinations.
Bordeaux ZA; Kwatra SG; Booth L; Dent P
Anticancer Drugs; 2023 Apr; 34(4):544-550. PubMed ID: 36847046
[TBL] [Abstract][Full Text] [Related]
4. HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody
Booth L; Roberts JL; Poklepovic A; Avogadri-Connors F; Cutler RE; Lalani AS; Dent P
Oncotarget; 2017 Oct; 8(52):90262-90277. PubMed ID: 29163826
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells
Booth L; West C; Von Hoff D; Dent P
Front Oncol; 2021; 11():677725. PubMed ID: 33937087
[TBL] [Abstract][Full Text] [Related]
6. Advances in Targeting Cutaneous Melanoma.
Kasakovski D; Skrygan M; Gambichler T; Susok L
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925915
[TBL] [Abstract][Full Text] [Related]
7. Camptothecin Inhibits Neddylation to Activate the Protective Autophagy Through NF-
Heng Y; Liang Y; Zhang J; Li L; Zhang W; Jiang Y; Wang S; Jia L
Front Oncol; 2021; 11():671180. PubMed ID: 33898327
[TBL] [Abstract][Full Text] [Related]
8. GZ17-6.02 kills PDX isolates of uveal melanoma.
Booth L; Roberts JL; Spasojevic I; Baker KC; Poklepovic A; West C; Kirkwood JM; Dent P
Oncotarget; 2024 May; 15():328-344. PubMed ID: 38758815
[TBL] [Abstract][Full Text] [Related]
9. GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells.
Booth L; Roberts JL; West C; Dent P
Oncotarget; 2024 Mar; 15():159-174. PubMed ID: 38441437
[TBL] [Abstract][Full Text] [Related]
10. GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells.
Booth MR; Booth L; Roberts JL; West C; Dent P
Oncotarget; 2024 Feb; 15():124-133. PubMed ID: 38329728
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides.
Bordeaux ZA; Reddy SV; Choi J; Braun G; McKeel J; Lu W; Yossef SM; Ma EZ; West CE; Kwatra SG; Kwatra MM
Sci Rep; 2024 Jan; 14(1):1955. PubMed ID: 38263212
[TBL] [Abstract][Full Text] [Related]
12. Topical GZ21T Inhibits the Growth of Actinic Keratoses in a UVB-Induced Model of Skin Carcinogenesis.
Bordeaux ZA; Choi J; Braun G; Davis C; Marani M; Lee K; Samuel C; Adams J; Windom R; Pollizzi A; Kambala A; Cornman H; Reddy SV; Lu W; Oladipo OO; Alphonse MP; West CE; Kwatra SG; Kwatra MM
JID Innov; 2023 Jul; 3(4):100206. PubMed ID: 37533581
[TBL] [Abstract][Full Text] [Related]
13. GZ17-6.02 kills prostate cancer cells
Booth L; Roberts JL; West C; Dent P
Front Oncol; 2022; 12():1045459. PubMed ID: 36408163
[TBL] [Abstract][Full Text] [Related]
14. GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma.
Choi J; Bordeaux ZA; McKeel J; Nanni C; Sutaria N; Braun G; Davis C; Miller MN; Alphonse MP; Kwatra SG; West CE; Kwatra MM
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456993
[TBL] [Abstract][Full Text] [Related]
15. GZ17-6.02 and axitinib interact to kill renal carcinoma cells.
Booth L; West C; Moore RP; Hoff DV; Dent P
Oncotarget; 2022; 13():281-290. PubMed ID: 35136485
[TBL] [Abstract][Full Text] [Related]
16. GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells.
Booth L; West C; Moore RP; Von Hoff D; Dent P
Oncotarget; 2022; 13():92-104. PubMed ID: 35035775
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
